← Product Code [KEA](/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/KEA) · K842028

# CM-TRISACRYL M DEAE-TRISACRYL M (K842028)

_Lkb Instruments, Inc. · KEA · Jun 7, 1984 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/KEA/K842028

## Device Facts

- **Applicant:** Lkb Instruments, Inc.
- **Product Code:** [KEA](/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/KEA.md)
- **Decision Date:** Jun 7, 1984
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.2230
- **Device Class:** Class 1
- **Review Panel:** Clinical Chemistry

## Regulatory Identification

A chromatographic separation material for clinical use is a device accessory (e.g., ion exchange absorbents, ion exchagne resins, and ion papers) intended for use in ion exchange chromatography, a procedure in which a compound is separated from a solution.

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/KEA/K842028](https://fda.innolitics.com/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/KEA/K842028)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com